Platelet aggregation in children with acute lymphoblastic leukemia during induction of remission therapy

Archives of Medical Research

Volumn 35, Issue 2, 2004, Pages 141-144

  Jaime Pérez, José Carlos ^a   Cantú Rodríguez, Olga Graciela ^a   Herrera Garza, José Luis ^a   Gómez Almaguer, David ^a  

^a UNIVERSIDAD AUTÓNOMA DE NUEVO LEÓN   (Mexico)

Author keywords

Acute lymphoblastic leukemia; Induction of remission therapy; Platelet aggregation; Platelet agonists; Platelet recovery time

Indexed keywords

ADENOSINE DIPHOSPHATE; ADRENALIN; COLLAGEN; RISTOCETIN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; CANCER DIAGNOSIS; CELL ACTIVITY; CELL STIMULATION; CHILD; CHILDHOOD; CLINICAL ARTICLE; CONTROLLED STUDY; EVALUATION; FEMALE; HEALTH STATUS; HUMAN; HUMAN CELL; IN VIVO STUDY; MALE; REMISSION; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; TREATMENT OUTCOME;

ADENOSINE DIPHOSPHATE; ADOLESCENT; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; COLLAGEN; EPINEPHRINE; FEMALE; HUMANS; IMMUNOPHENOTYPING; INFANT; LEUKEMIA, LYMPHOCYTIC, ACUTE; MALE; PLATELET ACTIVATION; PLATELET AGGREGATION; REMISSION INDUCTION; RISTOCETIN; TIME FACTORS; VASOCONSTRICTOR AGENTS;

EID: 1542328913     PISSN: 01884409     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arcmed.2003.10.004     Document Type: Article

References (20)

1. Chabner B.A., Wilson W., Supko J. Pharmacology and toxicity of antineoplastic drugs. Beutler E., Lichtman M.A., Coller B.S., Kipps T.J. Williams hematology. 6th ed. 2001;185-200 McGraw-Hill, New York.
2. Faderl S., Thall P.F., Kantarjian H.M., Estrov Z. Time to platelet recovery predicts outcome of patients with de novo acute lymphoblastic leukemia who have achieved a complete remission. Br J Haematol. 117:2002;869-874.
3. Ramos O.F., Moron E.C., De Castro-Arenas R. Platelet function abnormalities in acute leukemia. Haematologia. 4:1981;383-391.
4. Pui C.H., Jackson C.W., Chesney C., Lyles S.A., Bowman W.P., Abromowitch M., Simone J.V. Sequential changes in platelet function and coagulation in leukemic children treated with L-asparaginase, prednisone and vincristine. J Clin Oncol. 1:1983;380-385.
5. Naresh K.N., Sivasankaran P., Veliath A.J. Platelet function in acute leukemias. J Assoc Physicians India. 41:1993;377-388.
6. Shapiro A.D., Clarke S.L., Christian J.M., Odom L.F., Hathaway W.E. Thrombosis in children receiving L-asparaginase. Determining patients at risk. Am J Pediatr Hematol Oncol. 15:1993;400-405.
7. Shapiro R.S., Gerrard J.M., Ramsay N.K., Nesbit M.E., Coccia P.F., Stoddard S.F., Plow E.F., White J.G., Krivit W. Selective deficiency in collagen-induced platelet aggregation during L-asparaginase therapy. Am J Pediatr Hematol Oncol. 2:1980;207-212.
8. Pui C.H., Jackson C.W., Chesney C. Normal platelet function after therapy for acute lymphocytic leukemia. Arch Intern Med. 143:1983;73-74.
9. Nowak-Göttl U., Wermes C., Junker R., Koch H.G., Schobess R., Fleischhack G., Schwabe D., Ehrenforth S. Prospective evaluation of the thrombotic risk in children with acute lymphoblastic leukemia carrying the MTHFR TT 667 genotype, the prothrombin G20210A variant, and further prothrombotic risk factors. Blood. 93:1999;1595-1599.
10. Mitchell L.G., Sutor A.H., Andrew M. Hemostasis in childhood acute lymphoblastic leukemia: coagulopathy induced by disease or treatment. Semin Thromb Hemost. 21:1995;390-401.
11. Mitchell L.G., Andrew M., Hanna K., Abshire T., Halton J., Anderson R., Cherrick I., Desai S., Mahoney D., McCuster P., Wu J., Dahl G., Chait P., de Veber G., Lee K.J., Mikulis D., Ginsberg J., Way C. A prospective cohort study determining the prevalence of thrombotic events in children with acute lymphoblastic leukemia and a central venous line who are treated with L-asparaginase: results of the Prophylactic Antithrombin Replacement in Kids with Acute Lymphoblastic Leukemia Treated with Asparaginase (PARKAA) Study. Cancer. 97:2003;508-516.
12. Nowak-Göttl U., Alkhe E., Fleischhack G., Schwabe D., Schobess R., Schumann C., Wermes C., Junker R. Thromboembolic events in children with acute lymphoblastic leukemia (BFM protocols): prednisone versus dexamethasone administration. Blood. 101:2003;2529-2533.
13. Jaime-Pérez J.C., Gómez-Almaguer D. Platelet aggregation is stimulated by L-asparaginase in children with acute lymphoblastic leukemia and in normal individuals. Haematologica. 87:2002;891-892.
14. Schrappe M., Reiter A., Ludwig W.D., Harbott J., Zimmermann M., Hiddemann W., Niemeyer C., Henze G., Feldges A., Zintl F., Kornhuber B., Ritter J., Welte K., Gadner H., Riehm H. Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy: results of Trial ALL-BFM 90. German-Austrian-Swiss ALL-BFM Study Group. Blood. 95:2000;3310-3322.
15. McCabe W.M., Jennings L.K. Laboratory evaluation of platelet function. McCabe W.M., Jennings L.K. Platelet protocols, research and clinical laboratory procedures. 1999;27-68 Academic Press, San Diego, CA, USA.
16. th ed. 2001;339-390 Churchill Livingstone, London.
17. Cowan D.H., Graham R.C. Jr., Baunach D. The platelet defect in leukemia. Platelet ultrastructure, adenin nucleotide metabolism, and the release reaction. J Clin Invest. 56:1975;188-200.
18. Jaime-Pérez J.C., Gómez-Almaguer D. The complex nature of the prothrombotic state in acute lymphoblastic leukemia of childhood. Haematologica. 88:(07):2003;ELT25.
19. Balasubramanian V., Grabowski E., Bini A., Nemerson Y. Platelets, circulating tissue factor, and fibrin colocalize in ex vivo thrombi: real-time fluorescence images of thrombus formation and propagation under defined flow conditions. Blood. 100:2002;2787-2792.
20. Ahmad S.S., London F.S., Walsh N. The assembly of the factor X-activating complex on activated human platelets. J Thromb Haemost. 1:2003;48-59.